Anbio Biotechnology (NNNN)
Anbio Biotechnology Market Cap : 160.64M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 160.20M |
| November 16, 2026 | 170.30M |
| November 13, 2026 | 167.66M |
| November 12, 2026 | 166.79M |
| November 11, 2026 | 177.76M |
| November 10, 2026 | 166.79M |
| November 09, 2026 | 179.08M |
| November 06, 2026 | 170.74M |
| November 05, 2026 | 157.57M |
| November 04, 2026 | 161.52M |
| November 03, 2026 | 157.35M |
| November 02, 2026 | 154.06M |
| October 30, 2026 | 147.47M |
| October 29, 2026 | 163.28M |
| October 28, 2026 | 168.54M |
| October 27, 2026 | 162.84M |
| October 26, 2026 | 162.40M |
| October 23, 2026 | 167.23M |
| October 22, 2026 | 162.84M |
| October 21, 2026 | 163.28M |
| October 20, 2026 | 163.71M |
| October 19, 2026 | 143.52M |
| October 16, 2026 | 137.38M |
| October 15, 2026 | 144.84M |
| October 14, 2026 | 156.69M |
| Date | Value |
|---|---|
| October 13, 2026 | 186.98M |
| October 12, 2026 | 193.56M |
| October 09, 2026 | 204.53M |
| October 08, 2026 | 202.78M |
| October 07, 2026 | 215.07M |
| October 06, 2026 | 215.07M |
| October 05, 2026 | 211.99M |
| October 02, 2026 | 243.60M |
| October 01, 2026 | 276.08M |
| September 30, 2026 | 276.51M |
| September 29, 2026 | 270.37M |
| September 28, 2026 | 267.30M |
| September 25, 2026 | 276.51M |
| September 24, 2026 | 269.93M |
| September 23, 2026 | 265.98M |
| September 22, 2026 | 244.91M |
| September 21, 2026 | 249.30M |
| September 18, 2026 | 230.43M |
| September 17, 2026 | 245.79M |
| September 16, 2026 | 244.91M |
| September 15, 2026 | 241.84M |
| September 14, 2026 | 268.18M |
| September 11, 2026 | 278.27M |
| September 10, 2026 | 285.73M |
| September 09, 2026 | 283.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CureVac NV | 1.049B |
| PAION AG | 0.3888M |
| Epigenomics AG | 1.000M |
| ACADIA Pharmaceuticals, Inc. | 3.082B |
| Alkermes Plc | 7.876B |
Market Cap Related Metrics
| Price | 3.66 |